Immunotec Announces Changes to Management
Prior to joining Immunotec, Dr. Rod Milne was a key distributor at Mannatech, where he trained and supported a national and international sales team of over 9,000 people. He has created and developed successful marketing and training programs for the past 14 years and has been a featured speaker on marketing and sales training throughout the United States, Canada, United Kingdom, Denmark, Australia and New Zealand.
Prior to his involvement in the network marketing industry, Dr. Milne graduated from the Canadian Memorial Chiropractic College in Toronto. He ran a large multi-doctor clinic in Saskatoon, subsequent to which he headed a private practice in Seattle. Dr. Milne has also owned a consulting company which established programs for health care providers to market their services to clients and patients.
"I am very pleased to welcome Dr. Milne to the executive team ", said James A. Northrop, President and CEO of Immunotec Inc. "We thank Dan Murphy for his contribution to Immunotec over the past two years and wish him success in his future endeavours".
About Immunotec Inc.
Immunotec is a Network Marketing Company involved in the direct selling of scientifically validated natural health products and dietary supplements. The Company offers a lucrative business opportunity to its independent distributors. This business model provides Immunotec's network of people with an opportunity to earn a steady and recurring income, directly based on their level of involvement and performance. Individual distributors build their business by conveying product information and selling product to customers and by building teams of distributors to expand geographic penetration and market coverage to larger populations of customers.
Headquartered with manufacturing facilities near Montreal, Canada, the Company also subcontracts certain distribution logistics and capacity to support its activities in the United States, Europe, Mexico and The Caribbean.
The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at www.sedar.com and on the Company's website at www.immunotec.com. The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM.
